Skip to main content

Published locations for Temozolomide may help half of patients with aggressive pituitary tumors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Temozolomide may help half of patients with aggressive pituitary tumors

User login

  • Reset your password
  • /content/temozolomide-may-help-half-patients-aggressive-pituitary-tumors
  • /familypracticenews/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /internalmedicinenews/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /oncologypractice/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /clinicalendocrinologynews/article/134819/endocrine-cancer/temozolomide-may-help-half-patients
  • /hematology-oncology/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /endocrinology/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /internalmedicine/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive
  • /familymedicine/article/134819/endocrine-cancer/temozolomide-may-help-half-patients-aggressive